Philip D. Harvey, PhD

JCP
Prevalence and Determinants of Everyday Disability in Schizophrenia
Insights

October 31, 2024

In this video, Philip D. Harvey, PhD discusses the multifaceted nature of disability in schizophrenia, highlighting the impact of cognitive impairments, functional capacity, and negative symptoms on everyday outcomes...
JCP
The Role of Digital Phenotyping in Negative Symptoms Treatment Studies
Insights

October 31, 2024

In this video, Philip D. Harvey, PhD explores the use of digital phenotyping to track negative symptoms in schizophrenia. Through ecological momentary assessments (EMA) using GPS and actigraphy, the...
JCP
Anticholinergic Burden in Schizophrenia
Insights

October 31, 2024

In this video, Philip D. Harvey, PhD discusses anticholinergic burden in schizophrenia, highlighting its cognitive impact, particularly memory impairments linked to M1 receptor blockade. He underscores the heightened dementia...
JCP
Academic Highlights

May 4, 2021

What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical...
,
JCP
Educational Activity

March 23, 2021

Can a patient-centered approach to treatment be adopted for patients with schizophrenia? Can these patients take part in shared decision-making? Follow along as Dr Harvey shares his expertise.
JCP
Original Research

January 14, 2020

Cyberbullying has received much mainstream media attention, but controversy exists regarding its prevalence. This study examined the prevalence of cyberbullying in adolescent psychiatric inpatients and its relation to potential...
, , , et al
JCP
Original Research

May 15, 2018

The currently available dopamine-blocking antipsychotics haven' t been of much help with cognitive deficits in schizophrenia. This post hoc analysis of an RCT examines whether MIN-101, which combines sigma-2...
, , , et al
JCP
Letter to the Editor

October 26, 2016

, , , et al
JCP
Educational Activity

October 28, 2014

JCP
Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes
InfoPack

August 26, 2014

, , , et al
JCP
Supplement Article

June 5, 2014

JCP
Supplement Article

February 21, 2014

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe